Recent data have demonstrated that a blockade of the programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) signaling pathway are able to prevent lung cancer development in patients with tuberculosis [72]. Here, PDCD1 is linked to lung carcinoma.